首页> 外文期刊>Acta medica Iranica. >A COMPARISON OF VAGINAL MISOPROSTOL WITH INTRAVENOUS OXYTOCIN FOR CERVICAL RIPENING AND LABOR INDUCTION
【24h】

A COMPARISON OF VAGINAL MISOPROSTOL WITH INTRAVENOUS OXYTOCIN FOR CERVICAL RIPENING AND LABOR INDUCTION

机译:阴道米索前列醇与静脉内催产素进行宫颈增生和引产的比较

获取原文
获取外文期刊封面目录资料

摘要

Labor induction despite an unriped cervix is one of the most common indications of the use of prostoglandines. This clinical trial was performed to compare the effectiveness of oxytocin with misoprostol for induction of labor in Bahonar Hospital, Kermanllranfrom 1999 to 2000. Sixty pregnant women with indication for labor induction were randomly assignedto receive misoprostol or oxytocin. Misoprostol in tabletform, 25 μg, was placed in the posterior fornix and wasrepeatedeveryfour hours in the first group (to a maximum of 100 μg). The second group received intravenous oxytocin (21 μm/min). The results showed that 83.3% of women in the misoprostol group were delivered vaginally within 3.5-21 hours of the initiation of induction versus 76.7% within 4.5-17.5 hours in oxytocin group and there was no significant difference between them. The total cesarean rate was approximately similar in the two groups. Women receiving oxytocin had higher rate of cesarean for distocia (5 versus 1). The mean and median interval from induction to delivery were not significantly different between the two groups, (685% 223 and 710 minutes in the first group compared with 685±198 and 690 minutes in the second group, respectively). There were no significant differences in Apgar score and meconium staining between the two groups. Hyperstifflulationwas seen in a patient in the first group with neither low Apgar score nor adverse neonatal outcomes. This study showed that the outcome of induction was not significantly different in the two groups. Therefore regarding the advantages of misoprostol, it is recommended as an alternative to oxytocin.
机译:尽管宫颈未裂,但引产是使用prostoglandines的最常见迹象之一。这项临床试验的目的是比较催产素与米索前列醇在1999年至2000年间在Kermanllran的Bahonar医院引产的效果。随机将60名有分娩指征的孕妇接受米索前列醇或催产素的治疗。片剂形式的米索前列醇25μg被放置在后穹and中,在第一组中每四小时重复一次(最大剂量为100μg)。第二组接受静脉注射催产素(21μm/ min)。结果显示,米索前列醇组中有83.3%的妇女在诱导开始后的3.5-21小时内阴道分娩,而催产素组的妇女在4.5-17.5小时内分娩的率为76.7%,两者之间无显着差异。两组的总剖宫产率大致相似。接受催产素的妇女剖宫产手术的比率更高(5比1)。两组之间从诱导到分娩的平均间隔和中位数间隔无显着差异(第一组分别为685%223分钟和710分钟,而第二组分别为685±198分钟和690分钟)。两组之间的Apgar评分和胎粪染色无明显差异。在第一组既没有低Apgar评分又没有不利的新生儿结局的患者中见到过度僵硬。这项研究表明,两组的诱导结果没有显着差异。因此,关于米索前列醇的优点,建议作为催产素的替代品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号